Search

Your search keyword '"Deiva, Kumaran"' showing total 388 results

Search Constraints

Start Over You searched for: Author "Deiva, Kumaran" Remove constraint Author: "Deiva, Kumaran"
388 results on '"Deiva, Kumaran"'

Search Results

1. Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II

4. Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS

6. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

7. Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis

9. Myelin-oligodendrocyte glycoprotein antibody-associated disease

13. E.U. paediatric MOG consortium consensus: Part 3 – Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

14. E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

15. E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

16. E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

17. E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

20. An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision

22. Anticoagulation helps shrink giant venous lakes and arteriovenous fistulas in dural sinus malformation.

23. The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years—Protocol, recruitment status, and baseline characteristics.

24. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis

29. Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein (MOG) antibodies levels associate with different disease course of MOG-associated disease in children

31. Long Term Clinical and Biological Prognostic Factors of Anti-Nmda Receptor Encephalitis in Children

33. Long‐term outcome of paediatricanti‐ N ‐methyl‐D‐ aspartate receptor encephalitis

35. Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis

37. Whole-body MR imaging in suspected physical child abuse: comparison with skeletal survey and bone scintigraphy findings from the PEDIMA prospective multicentre study

38. Long‐term outcome of paediatric anti‐N‐methyl‐D‐aspartate receptor encephalitis.

40. Arteriovenous Cerebral High Flow Shunts in Children: From Genotype to Phenotype

41. CONNECT : étude ouverte, avec contrôle actif, portant sur le diméthylfumarate (DMF) chez des patients pédiatriques atteints de sclérose en plaques récurrente-rémittente

42. sj-docx-1-msj-10.1177_13524585221078825 ��� Supplemental material for Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II

44. Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis.

47. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study

48. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

49. Glial Fibrillary Acidic Protein Autoimmunity

50. Intracerebral Gene Therapy in Four Children with Sanfilippo B Syndrome: 5.5-Year Follow-Up Results

Catalog

Books, media, physical & digital resources